Weight-Loss Jab Wegovy to Be Offered on NHS for People at Risk of Further Heart Attacks

Vaccine cutting hospital admissions in some of the most at-risk patients

RSV vaccine cuts hospital admissions by 75 in Welsh over-75s, says Public Health Wales. Programme expands to over-80s.

What to know about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight

Known as “triple-G,” injectable retatrutide levies a triple whammy on the GLP-1, GIP and glucagon hormones, whereas most other drugs on the market only mimic one or two of those hormones.

Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details

The Centre has issued a detailed advisory on GLP-1 receptor agonist drugs, emphasizing their use for type 2 diabetes and obesity must be strictly under medical supervision. Authorities are increasing regulatory surveillance and warning of strict action against violations in their sale or prescription.

1.2m Brits to receive ‘life-changing’ weight loss drug Wegovy over heart attack fears

More than a million people with heart disease are to be prescribed the weight loss jab Wegovy.

More than a million could be offered Wegovy to cut heart attack and stroke risk

Wegovy weight-loss drug set for NHS rollout to over 1 million UK patients with heart disease, after NICE draft guidance.

Weight-loss jab Wegovy to be offered on NHS for people at risk of further heart attacks

More than a million people in England will start being offered the anti-obesity jab for better heart health and to avoid strokes.